Somatostatin Receptor SSTR-2a Expression Is a Stronger Predictor for Survival Than Ki-67 in Pancreatic Neuroendocrine Tumors

Somatostatin receptors (SSTR) are commonly expressed by neuroendocrine tumors. Expression of SSTR-2a and SSTR-5 may impact symptomatic management; however, the impact on survival is unclear. The aim of this study is to correlate SSTR-2a and SSTR-5 expression in pancreatic neuroendocrine tumors (PNET...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Shreya, de Reuver, Philip R., Gill, Preetjote, Andrici, Juliana, D’Urso, Lisa, Mittal, Anubhav, Pavlakis, Nick, Clarke, Stephen, Samra, Jaswinder S., Gill, Anthony J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
7100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616753/
https://www.ncbi.nlm.nih.gov/pubmed/26447992
http://dx.doi.org/10.1097/MD.0000000000001281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616753/
https://www.ncbi.nlm.nih.gov/pubmed/26447992
http://dx.doi.org/10.1097/MD.0000000000001281

Ejemplares similares